The Dubai Stem Cell Congress (DSCC 2025) commenced today at The Ritz-Carlton, DIFC, bringing together over 500 delegates, including leading scientists, medical professionals, and industry experts.
Organized by First Stem Cell and Genomics Laboratory and supported by the Dubai Health Authority, the event highlights the latest breakthroughs in stem cell and regenerative medicine.
The opening ceremony featured a welcome address, the UAE national anthem, and an introductory video showcasing First Stem Cell and Genomics Laboratory’s contributions to advancing stem cell research in the UAE.
Dr. Fatma Al Hashimi, Chairperson of DSCC and Director of First Stem Cell and Genomics Laboratory, delivered the keynote speech, underscoring the significance of stem cell research, its clinical applications, and public awareness. She emphasized FDA-approved stem cell therapies for blood cancers, thalassemia, and autoimmune diseases.
Hassan Al Hashemi, Vice President of the Chamber of Commerce Executive Office, also addressed the audience, highlighting Dubai’s growing role as a global biotechnology and regenerative medicine hub through innovation and collaboration.
A key highlight of the ceremony was the awarding of Good Manufacturing Practice (GMP) certification to First Stem Cell and Genomics Laboratory, making it the first GMP-certified stem cell lab in the UAE. This milestone ensures the highest safety and quality standards in stem cell processing and therapy, solidifying Dubai’s leadership in the field.
The event concluded with an award ceremony and a special performance, setting the stage for two days of in-depth discussions, scientific presentations, and workshops on the future of stem cell and gene therapy.
News Source: Emirates News Agency
